Interference with the absorption of levothyroxine

Current Opinion in Endocrinology and Diabetes

Volumn 10, Issue 5, 2003, Pages 347-352

  Singh, Nalini ^a,c   Hershman, Jerome M ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID SEQUESTRANT; FERROUS SULFATE; LEVOTHYROXINE; SUCRALFATE;

DRUG ABSORPTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPOTHYROIDISM; PRESCRIPTION; REVIEW; THYROID TUMOR;

EID: 12344256358     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-200310000-00008     Document Type: Review

References (33)

1. Hays MT: Absorption of oral thyroxine in man. J Clin Endocrinol Metab 1968, 28:749-756.
2. Hasselstrom K, Siersbaek-Nielsen K, Lumholtz IB, et al.: The bioavailability of thyroxine and 3,5,3′-triiodothyronine in normal subjects and in hyper and hypothyroid patients. Acta Endocrinol 1985, 110:483-486.
3. Hays MT: Localization of human thyroxine absorption. Thyroid 1991, 1:241-248.
4. Hays MT, Nielsen KRK: Human thyroxine absorption: age effects and methodological analyses. Thyroid 1994, 4:55-64.
5. Read DG, Hays MT, Hershman JM: Absorption of oral thyroxine in hypothyroid and normal man. J Clin Endocrinol Metab 1970, 30:798-799.
6. Greenstadt MA, Spencer CA, Lum SMC, et al.: Nonisotopic method for determination of oral thyroxine absorption. In Hormone drugs: proceedings of the FDA-USP workshop on drug and reference standards for insulins, somatropins, and thyroid-axis hormones. Edited by Gueriguian JL, Bransome ED, Outschoorn AS. Rockville, MD: United States Pharmacopeial Convention Inc.; 1982:534-539.
7. Nicoloff JT, Low JC, Dussault JH, et al.: Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man. J Clin Invest 1972, 51:473-483.
8. Azizi F, Belur R, Albano J: Malabsorption of thyroid hormones after jejunoileal bypass for obesity. Ann Intern Med 1979, 90:941-942.
9. Topliss DJ, Wright JA, Volpe R: Increased requirement for thyroid hormone after a jejunoileal bypass operation. CMAJ 1980, 123:765-766.
10. Bevan JS, Munro JF: Thyroxine malabsorption following intestinal bypass surgery. Int J Obesity 1986, 10:245-246.
11. Stone E, Leiter LA, Lambert JR, et al.: L-thyroxine absorption in patients with short bowel. J Clin Endocrinol Metab 1984, 59:139-141.
12. Janerot G, Kagedal B, Von Schenk H, et al.: The thyroid in ulcerative colitis and Crohn's disease. Acta Med Scan 1976, 199:229.
13. Vanderschuren-Lodeweyckx M, Eggermont E, Cornette C, et al.: Decreased serum thyroid hormone levels and increased TSH response to TRH in infants with coeliac disease. Clin Endocrinol 1977, 6:361.
14. 4 bioavailability may be accentuated in patients with pre-existing malabsorption disorders.
15. 4 greater than 2 μg/kg/d.
16. Benvenga S, Bartolone L, Squadrito S, et al.: Delayed intestinal absorption of levothyroxine. Thyroid 1995, 5:249-253.
17. Ain KB, Refetoff S, Fein HG, et al.: Pseudomalabsorption of levothyroxine. JAMA 1991, 266:2118-2120.
18. Liel Y, Harman-Boehm I, Shany S: Evidence for a clinically important adverse effect of fiber-enriched diet on the bioavailability of levothyroxine in adult hypothyroid patients. J Clin Endocrin Metab 1996, 81:857-859.
19. Chiu AC, Sherman SI: Effects of pharmacological fiber supplements on levothyroxine absorption. Thyroid 1998, 8:667-671.
20. Northcutt RC, Stiel JN, Hollifield JW, et al.: The influence of cholestyramine on thyroxine absorption. JAMA 1969, 208:1857-1861.
21. McLean M, Kirkwood I, Epstein M, et al.: Cation-exchange resin and inhibition of intestinal absorption of thyroxine. Lancet 1993, 341:1286.
22. Campbell NRC, Hasinoff BB, Stalls H, et al.: Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med 1992, 117:1010-1013.
23. Shakir KMM, Chute JP, Aprill BS, et al.: Ferrous sulfate-induced increase in requirement for thyroxine in a patient with primary hypothyroidism. South Med J 1997, 90:637-639.
24. Sherman SI, Tielens ET, Ladenson PW: Sucralfate causes malabsorption of L-thyroxine. Am J Med 1994, 96:531-535.
25. Havrankova J, Lahaie R: Levothyroxine binding by sucralfate. Ann Int Med 1992, 117:445-446.
26. Campbell JA, Schmidt BA, Bantle JP: Sucralfate and the absorption of L-thyroxine. Ann Intern Med 1994, 121:152.
27. Sperber AD, Liel Y: Evidence for interference with the intestinal absorption of levothyroxine sodium by aluminum hydroxide. Arch Intern Med 1992, 152:183-184.
28. Liel Y, Sperber AD, Shany S: Nonspecific intestinal adsorption of levothyroxine by aluminum hydroxide. Am J Med 1994, 97:363-365.
29. Mersebach H, Rasmussen AK, Kirkegaard L, et al.: Intestinal adsorption of levothyroxine by antacids and laxatives: case stories and in vitro experiments. Pharmacol Toxicol 1999, 84:107-109.
30. Schneyer CR: Calcium carbonate and reduction of levothyroxine efficacy [Letter]. JAMA 1998, 279:750.
31. 4 absorption.
32. 4 absorption.
33. Jauk B, Mikosch P, Gallowitsch HJ, et al.: Case history: unusual malabsorption of levothyroxine. Thyroid 2000, 10:93-95.